Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CUE

Cue Biopharma Inc

May 01 • 04:00PM ET

30.42

+15.68 106.38 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AMGN BMY GILD BMRN REGN BIIB VRTX INCY SAGE FATE

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.40	Insider Own	0.56%	Shs Outstand	3.26M	Perf Week	71.91%
Market Cap	99.03M	Forward P/E	-	EPS next Y	-18.00	Insider Trans	-	Shs Float	3.24M	Perf Month	400.49%
Enterprise Value	76.09M	PEG	-	EPS next Q	-	Inst Own	22.31%	Short Float	7.76%	Perf Quarter	202.87%
Income	-26.60M	P/S	3.61	EPS this Y	-107.14%	Inst Trans	-	Short Ratio	0.68	Perf Half Y	46.96%
Sales	27.47M	P/B	3.71	EPS next Y	-3.45%	ROA	-70.62%	Short Interest	0.25M	Perf YTD	232.02%
Book/sh	8.21	P/C	3.65	EPS next 5Y	-	ROE	-121.11%	52W High	30.97 -1.77%	Perf Year	34.88%
Cash/sh	8.34	P/FCF	-	EPS past 3/5Y	42.63% 29.04%	ROIC	-92.63%	52W Low	4.97 511.95%	Perf 3Y	-77.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	180.45% 54.16%	Gross Margin	95.89%	Volatility	45.09% 42.90%	Perf 5Y	-91.64%
Dividend TTM	-	EV/Sales	2.77	EPS Y/Y TTM	58.21%	Oper. Margin	-96.56%	ATR (14)	5.81	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.74	Sales Y/Y TTM	195.75%	Profit Margin	-96.85%	RSI (14)	69.77	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.74	EPS Q/Q	111.21%	SMA20	93.42%	Beta	2.39	Target Price	115.00
Payout	-	Debt/Eq	0.16	Sales Q/Q	1292.26%	SMA50	171.60%	Rel Volume	50.77	Prev Close	14.74
Employees	29	LT Debt/Eq	0.09	Earnings	Mar 16 AMC	SMA200	82.83%	Avg Volume	370.56K	Price	30.42
IPO	Jan 02, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	111.11% 2094.20%	Trades		Volume	18,812,775	Change	106.38%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)